A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia

Qin, X., Tran, B.G., Kim, M.J. et al. (7 more authors) (2017) A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia. International Journal of Antimicrobial Agents. ISSN 0924-8579

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Ceftazidime/avibactam; Complicated intra-abdominal infection; Phase 3; Efficacy; Safety; Asia
Dates:
  • Published (online): 29 March 2017
  • Accepted: 6 January 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Mathematics and Statistics (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Apr 2017 10:57
Last Modified: 25 Apr 2017 10:57
Published Version: https://doi.org/10.1016/j.ijantimicag.2017.01.010
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ijantimicag.2017.01.010

Share / Export

Statistics